XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock Issued
Common Stock in Treasury
Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2021   24,679,000        
Beginning balance at Dec. 31, 2021 $ 275,949 $ 247 $ (355,159) $ 314,094 $ (13,524) $ 330,291
Beginning balance (in shares) at Dec. 31, 2021     (11,861,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (2,910)         (2,910)
Currency translation adjustment 1,849       1,849  
Shares issued for employee benefit plan and compensation (in shares)   145,000        
Shares issued for employee benefit plan and compensation 324 $ 1   323    
Purchase of treasury shares (in shares)     (225,000)      
Purchase of treasury shares (7,354)   $ (7,354)      
Shares issued to directors (in shares)   7,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,499     2,499    
Ending balance (in shares) at Mar. 31, 2022   24,831,000        
Ending balance at Mar. 31, 2022 270,357 $ 248 $ (362,513) 316,916 (11,675) 327,381
Ending balance (in shares) at Mar. 31, 2022     (12,086,000)      
Beginning balance (in shares) at Dec. 31, 2021   24,679,000        
Beginning balance at Dec. 31, 2021 275,949 $ 247 $ (355,159) 314,094 (13,524) 330,291
Beginning balance (in shares) at Dec. 31, 2021     (11,861,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss 7,312          
Currency translation adjustment $ (12,831)          
Purchase of treasury shares (in shares) (358,000)          
Purchase of treasury shares $ (11,297)          
Ending balance (in shares) at Sep. 30, 2022   24,893,000        
Ending balance at Sep. 30, 2022 267,660 $ 249 $ (366,456) 322,619 (26,355) 337,603
Ending balance (in shares) at Sep. 30, 2022     (12,219,000)      
Beginning balance (in shares) at Mar. 31, 2022   24,831,000        
Beginning balance at Mar. 31, 2022 270,357 $ 248 $ (362,513) 316,916 (11,675) 327,381
Beginning balance (in shares) at Mar. 31, 2022     (12,086,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss 2,988         2,988
Currency translation adjustment (7,313)       (7,313)  
Shares issued for employee benefit plan and compensation (in shares)   23,000        
Shares issued for employee benefit plan and compensation 302 $ 1   301    
Purchase of treasury shares (in shares)     (130,000)      
Purchase of treasury shares (3,857)   $ (3,857)      
Shares issued to directors (in shares)   8,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,637     2,637    
Ending balance (in shares) at Jun. 30, 2022   24,862,000        
Ending balance at Jun. 30, 2022 265,114 $ 249 $ (366,370) 319,854 (18,988) 330,369
Ending balance (in shares) at Jun. 30, 2022     (12,216,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss 7,234         7,234
Currency translation adjustment (7,367)       (7,367)  
Shares issued for employee benefit plan and compensation (in shares)   24,000        
Shares issued for employee benefit plan and compensation 326     326    
Purchase of treasury shares (in shares)     (3,000)      
Purchase of treasury shares (86)   $ (86)      
Shares issued to directors (in shares)   7,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,439     2,439    
Ending balance (in shares) at Sep. 30, 2022   24,893,000        
Ending balance at Sep. 30, 2022 267,660 $ 249 $ (366,456) 322,619 (26,355) 337,603
Ending balance (in shares) at Sep. 30, 2022     (12,219,000)      
Beginning balance (in shares) at Dec. 31, 2022   25,000,000        
Beginning balance at Dec. 31, 2022 $ 268,406 $ 250 $ (368,194) 326,839 (21,187) 330,698
Beginning balance (in shares) at Dec. 31, 2022 (12,295,305)   (12,295,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (61,363)         (61,363)
Currency translation adjustment 1,916       1,916  
Shares issued for employee benefit plan and compensation (in shares)   189,000        
Shares issued for employee benefit plan and compensation 352 $ 2   350    
Purchase of treasury shares (in shares)     (53,000)      
Purchase of treasury shares (812)   $ (812)      
Shares issued to directors (in shares)   8,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,540     2,540    
Ending balance (in shares) at Mar. 31, 2023   25,197,000        
Ending balance at Mar. 31, 2023 211,039 $ 252 $ (369,006) 329,729 (19,271) 269,335
Ending balance (in shares) at Mar. 31, 2023     (12,348,000)      
Beginning balance (in shares) at Dec. 31, 2022   25,000,000        
Beginning balance at Dec. 31, 2022 $ 268,406 $ 250 $ (368,194) 326,839 (21,187) 330,698
Beginning balance (in shares) at Dec. 31, 2022 (12,295,305)   (12,295,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (91,136)          
Currency translation adjustment $ (2,702)          
Purchase of treasury shares (in shares) (61,000)          
Purchase of treasury shares $ (888)          
Ending balance (in shares) at Sep. 30, 2023   25,301,000        
Ending balance at Sep. 30, 2023 $ 181,527 $ 253 $ (369,082) 334,683 (23,889) 239,562
Ending balance (in shares) at Sep. 30, 2023 (12,356,603)   (12,356,000)      
Beginning balance (in shares) at Mar. 31, 2023   25,197,000        
Beginning balance at Mar. 31, 2023 $ 211,039 $ 252 $ (369,006) 329,729 (19,271) 269,335
Beginning balance (in shares) at Mar. 31, 2023     (12,348,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (10,411)         (10,411)
Currency translation adjustment (3,117)       (3,117)  
Shares issued for employee benefit plan and compensation (in shares)   50,000        
Shares issued for employee benefit plan and compensation 373 $ 1   372    
Purchase of treasury shares (in shares)     (5,000)      
Purchase of treasury shares (43)   $ (43)      
Shares issued to directors (in shares)   7,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,158     2,158    
Ending balance (in shares) at Jun. 30, 2023   25,254,000        
Ending balance at Jun. 30, 2023 199,999 $ 253 $ (369,049) 332,259 (22,388) 258,924
Ending balance (in shares) at Jun. 30, 2023     (12,353,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (19,362)         (19,362)
Currency translation adjustment (1,501)       (1,501)  
Shares issued for employee benefit plan and compensation (in shares)   40,000        
Shares issued for employee benefit plan and compensation 289     289    
Purchase of treasury shares (in shares)     (3,000)      
Purchase of treasury shares (33)   $ (33)      
Shares issued to directors (in shares)   7,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,135     2,135    
Ending balance (in shares) at Sep. 30, 2023   25,301,000        
Ending balance at Sep. 30, 2023 $ 181,527 $ 253 $ (369,082) $ 334,683 $ (23,889) $ 239,562
Ending balance (in shares) at Sep. 30, 2023 (12,356,603)   (12,356,000)